User profiles for Jon Brudvig

Jon Brudvig

Amicus Therapeutics, Sanford Research, University of South Dakota
Verified email at amicusrx.com
Cited by 230

[HTML][HTML] X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease

JJ Brudvig, JM Weimer - Frontiers in cellular neuroscience, 2015 - frontiersin.org
Intracellular protein-protein interactions are dynamic events requiring tightly regulated
spatial and temporal checkpoints. But how are these spatial and temporal cues integrated to …

On the cusp of cures: breakthroughs in Batten disease research

JJ Brudvig, JM Weimer - Current Opinion in Neurobiology, 2022 - Elsevier
Batten disease is a family of rare, lysosomal disorders caused by mutations in one of at least
13 genes, which encode a diverse set of lysosomal and extralysosomal proteins. Despite …

[HTML][HTML] AAV9 gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-batten disease

TB Johnson, KA White, JJ Brudvig, JT Cain, L Langin… - Molecular Therapy, 2021 - cell.com
CLN8 disease is a rare form of neuronal ceroid lipofuscinosis caused by biallelic mutations
in the CLN8 gene, which encodes a transmembrane endoplasmic reticulum protein involved …

[HTML][HTML] Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice

…, B Lu, TB Johnson, S Davis, MA Pratt, J Brudvig… - … Therapy-Methods & …, 2021 - cell.com
Batten disease is a family of rare, fatal, neuropediatric diseases presenting with memory/learning
decline, blindness, and loss of motor function. Recently, we reported the use of an …

Glycerophosphoinositol is Elevated in Blood Samples From CLN3Δex7-8 pigs, Cln3Δex7-8 Mice, and CLN3-Affected Individuals

JJ Brudvig, VJ Swier, TB Johnson, JC Cain… - Biomarker …, 2022 - journals.sagepub.com
Introduction: CLN3 Batten disease is a rare pediatric neurodegenerative lysosomal disorder
caused by biallelic disease-associated variants in CLN3. Despite decades of intense …

[HTML][HTML] Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease

TB Johnson, JJ Brudvig, S Likhite, MA Pratt… - Frontiers in …, 2023 - frontiersin.org
CLN3 disease, caused by biallelic mutations in the CLN3 gene, is a rare pediatric
neurodegenerative disease that has no cure or disease modifying treatment. The development of …

Collagen has a unique SEC24 preference for efficient export from the endoplasmic reticulum

CL Lu, S Ortmeier, J Brudvig, T Moretti, J Cain… - Traffic, 2022 - Wiley Online Library
SEC24 is mainly involved in cargo sorting during COPII vesicle assembly. There are four
SEC24 paralogs (A–D) in vertebrates, which are classified into two subgroups (SEC24A/B and …

[HTML][HTML] Transmembrane batten disease proteins interact with a shared network of vesicle sorting proteins, impacting their synaptic enrichment

…, G Ferrandino, DG May, KJ Roux, JJ Brudvig… - Frontiers in …, 2022 - frontiersin.org
Batten disease is unique among lysosomal storage disorders for the early and profound
manifestation in the central nervous system, but little is known regarding potential neuron-…

[HTML][HTML] A novel porcine model of CLN2 Batten disease that recapitulates patient phenotypes

…, FA Rohret, CS Rogers, DA Pearce, JJ Brudvig… - …, 2022 - Elsevier
CLN2 Batten disease is a lysosomal disorder in which pathogenic variants in CLN2 lead to
reduced activity in the enzyme tripeptidyl peptidase 1. The disease typically manifests around …

[HTML][HTML] A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes

…, W Pfeifer, CS Rogers, JJ Brudvig… - Disease models & …, 2023 - journals.biologists.com
Mouse models of CLN3 Batten disease, a rare lysosomal storage disorder with no cure, have
improved our understanding of CLN3 biology and therapeutics through their ease of use …